tiprankstipranks
Trending News
More News >
Assure Holdings (IONM)
OTHER OTC:IONM

Assure Holdings (IONM) AI Stock Analysis

Compare
93 Followers

Top Page

IO

Assure Holdings

(OTC:IONM)

Rating:29Underperform
Price Target:
Assure Holdings receives a low overall stock score due to significant financial difficulties, including declining revenues and consistent losses. Negative technical indicators and poor valuation metrics further weigh down the stock's prospects. The absence of recent earnings call data and corporate events limits the assessment of potential recovery or strategic shifts.

Assure Holdings (IONM) vs. SPDR S&P 500 ETF (SPY)

Assure Holdings Business Overview & Revenue Model

Company DescriptionAssure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. The company has operations in Arizona, Colorado, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, Pennsylvania, South Carolina, Texas, and Utah, the United States. Assure Holdings Corp. is based in Englewood, Colorado.
How the Company Makes MoneyAssure Holdings generates revenue primarily by providing intraoperative neuromonitoring services to hospitals and surgical centers. The company employs technologists who work in the operating room and neurologists who monitor the procedures remotely. Revenue is earned through service fees charged to healthcare facilities and insurance reimbursements for the monitoring services provided. Key factors contributing to its earnings include partnerships with hospitals, surgical centers, and insurance companies to facilitate the delivery and reimbursement of these essential medical services.

Assure Holdings Financial Statement Overview

Summary
Overall, Assure Holdings is facing severe financial challenges, evidenced by declining revenues, consistent losses, negative margins, and a strained balance sheet. The company has a high debt burden relative to its assets and is reliant on external financing to maintain operations. These factors suggest potential risks and uncertainties in the company's financial health and future prospects.
Income Statement
20
Very Negative
Assure Holdings has experienced a significant decline in revenue over recent years, with the latest annual revenue being just 255,000 compared to 29.2 million in 2021. The gross profit margin is negative due to higher costs than revenue, and net income has consistently been negative, indicating sustained losses. The company also shows negative EBIT and EBITDA margins, highlighting operational challenges and a lack of profitability.
Balance Sheet
15
Very Negative
The balance sheet reflects financial instability, with shareholders' equity turning negative in the latest period, indicating liabilities exceed assets. The debt-to-equity ratio is not calculable due to negative equity, but the high level of debt relative to total assets suggests significant leverage. The return on equity is negative, further emphasizing the company's struggles to generate returns for shareholders.
Cash Flow
25
Negative
Assure Holdings has faced consistent negative free cash flow, although there was a slight improvement in operating cash flow in 2023 compared to 2022. The operating cash flow to net income ratio suggests that cash outflows from operations exceed net losses, and financing activities have been necessary to sustain operations, indicating reliance on external funding.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
78.00K255.00K10.98M29.19M3.52M17.73M
Gross Profit
-1.22M-2.19M-4.21M14.87M-4.39M12.77M
EBIT
-18.09M-20.08M-27.82M-2.13M-16.20M2.37M
EBITDA
-20.68M-19.82M-18.19M-1.39M-15.19M2.91M
Net Income Common Stockholders
-20.52M-26.08M-30.11M-2.76M-15.04M2.72M
Balance SheetCash, Cash Equivalents and Short-Term Investments
45.00K123.00K905.00K4.02M4.39M59.00K
Total Assets
5.28M7.51M24.25M48.41M33.64M44.38M
Total Debt
15.60M14.80M14.35M15.87M7.64M6.21M
Net Debt
15.56M14.68M13.45M11.85M3.26M6.16M
Total Liabilities
23.92M22.85M18.78M19.45M14.43M34.49M
Stockholders Equity
-18.64M-15.34M5.46M28.96M19.21M9.89M
Cash FlowFree Cash Flow
-3.43M-5.04M-8.11M-12.94M-2.85M-4.28M
Operating Cash Flow
-3.43M-5.04M-8.03M-13.37M-2.53M-4.23M
Investing Cash Flow
1.88M-471.00K-280.00K1.00K-7.50M465.00K
Financing Cash Flow
-1.55M4.73M5.20M13.01M14.36M2.99M

Assure Holdings Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.05
Price Trends
50DMA
0.04
Positive
100DMA
0.07
Negative
200DMA
2.36
Negative
Market Momentum
MACD
<0.01
Positive
RSI
49.48
Neutral
STOCH
120.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IONM, the sentiment is Neutral. The current price of 0.05 is below the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.04, and below the 200-day MA of 2.36, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 49.48 is Neutral, neither overbought nor oversold. The STOCH value of 120.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IONM.

Assure Holdings Risk Analysis

Assure Holdings disclosed 53 risk factors in its most recent earnings report. Assure Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Assure Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$5.38B3.40-45.06%3.28%16.75%-0.02%
38
Underperform
$3.27M-1023.93%83.04%
37
Underperform
$1.82M-120.16%-7.74%93.25%
29
Underperform
$175.64K170.06%
28
Underperform
$2.93M-120.01%97.84%
$2.81M-33.24%
$1.84M-30.84%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IONM
Assure Holdings
0.05
-9.18
-99.46%
WINT
Windtree Therapeutics
0.70
-149.30
-99.53%
APVO
Aptevo Therapeutics
4.65
-608.59
-99.24%
ENTO
Entero Therapeutics
0.57
-1.50
-72.46%
RSLS
ReShape Lifesciences
2.29
-300.91
-99.24%
WORX
SCWorx
0.52
-1.53
-74.63%

Assure Holdings Corporate Events

M&A TransactionsLegal Proceedings
Assure Holdings Settles Merger Disputes with Wellgistics
Neutral
Dec 23, 2024

Assure Holdings Corp. has settled all disputes with Wellgistics Health, Inc., formerly Danam Health, Inc., and Assure Acquisition Corp., related to a previously planned merger. As part of the Settlement Agreement, the associated Convertible Note was cancelled, and it was confirmed that no party owes any termination fees or other amounts, effectively ending the merger discussions and any related obligations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.